TPV/∆66R/m-IL-2/mCherry and TPV/∆66R/m-CCL-2/mCherry virotherapy in immune-reconstituted animals demonstrated similar trends over the course of the study, with the results from both recombinants showing less overall regression in tumor volume compared to control (Figure 2B,C). Here, IL2 is linked to neoplasm.